Recent outbreaks of Zika virus in Oceania and Latin America, accompanied by unexpected clinical complications, made this infection a global public health concern. This virus has tropism to neural tissue, leading to microcephaly in newborns in a significant proportion of infected mothers. The clinical relevance of this infection, the difficulty to perform accurate diagnosis and the small amount of data in literature indicate the necessity of studies on Zika infection in order to characterize new biomarkers of this infection and to establish new targets for viral control in vertebrates and invertebrate vectors. Thus, this study aims at establishing a lipidomics profile of infected mosquito cells compared to a control group to define potential targets for viral control in mosquitoes. Thirteen lipids were elected as specific markers for Zika virus infection (Brazilian strain), which were identified as putatively linked to the intracellular mechanism of viral replication and/or cell recognition. Our findings bring biochemical information that may translate into useful targets for breaking the transmission cycle.
Citation: Melo CFOR, de Oliveira DN, Lima EdO, Guerreiro TM, Esteves CZ, Beck RM, et al. (2016) A Lipidomics Approach in the Characterization of Zika-Infected Mosquito Cells: Potential Targets for Breaking the Transmission Cycle. PLoS ONE 11(10): e0164377. https://doi.org/10.1371/journal.pone.0164377
Editor: Humberto Lanz-Mendoza, Instituto Nacional de Salud Pública, MEXICO
Received: July 19, 2016; Accepted: September 24, 2016; Published: October 10, 2016
Copyright: © 2016 Melo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: We acknowledge funding from Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP – São Paulo Research Foundation), under the following Grant numbers: 2011/50400-0 and 2015/06809-1 for RRC, 2014/00084-2 for DNO, 2014/00302-0 for CZE, 2013/11343-6 for JASN) JANS is a FAPESP Young Investigator. We also thank CAPES and CNPq for the fellowships for CFORM, EOL and TMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors declare no competing financial interests.
Zika virus (ZIKV) is an emerging arbovirus that is transmitted by mosquitoes of the genus Aedes , and was first isolated in 1947 in eastern Africa, remaining restricted to the African and Asian continents until 2007, where it was seldom observed in humans . Typically, the infection of ZIKV in humans is either asymptomatic or associated with a self-limiting febrile illness, in only 20% of infected people. However, recent outbreaks of ZIKV in South Pacific and Latin America have evidenced the virus potential to cause severe neurological damage-associated complications such as Guillain-Barré syndrome  and microcephaly in newborns .
Similarly to dengue virus (DENV), ZIKV is an enveloped, single-stranded, positive RNA virus whose 10.7-kb genome encodes three structural proteins (C, capsid; M, membrane; and E, envelope) and seven nonstructural proteins (NS1, NS2a, NS2b, NS3, NS4a, NS4b and NS5) [2, 5]. E protein is a major ZIKV antigen, which coordinates the association between the virion and the host’s viral receptors and membrane lipids [6, 7]. Recent studies have demonstrated that viral and host lipids play an important role in the attachment process during viral infection. These lipids, adhered to the capsid surface, coordinate viral recognition allowing its entry into the host cell [8–13].
Intracellular host cell membranes multiply and reorganize during infection in order to form viral replication complexes (VRCs), leading to the accumulation of phosphatidylcholine (PC) in VRCs, as demonstrated for Poliovirus and Hepatitis C . Furthermore, VRC biogenesis requires increased membrane fluidity in order to facilitate viral RNA transfer throughout pores formed on the packing vesicles . Strikingly, a recent lipidomics study has demonstrated that intracellular membrane alterations induced by DENV are intimately associated with a set of lipids uniquely found on DENV-infected mosquito cells, especially in association with VCR membranes , highlighting the crucial role of such molecules in this process.
On the other hand, lipid droplets (LDs) have been recently pointed out as an important component of the A. aegypti antiviral defenses , which also rely on the RNAi machinery  and innate immune pathways Toll and JAK-STAT [18, 19] to contain viral replication. LDs accumulate upon bacterial and viral infections in both adult mosquito midgut and cell lines, in a process that seems to be associated with NF-k-B immune pathways activation with participation of the insect gut microbiota .
While much progress has been achieved in the past decade towards understanding the mosquito’s transcriptional and metabolic responses to DENV infection, mosquito-ZIKV interactions continue largely unknown. In addition to the limitations of both clinical and laboratory diagnosis and the absence of a specific treatment for ZIKV infection [2, 20, 21], this poses a major challenge for the development of control interventions.
The present study aims at verifying the alterations in the mosquito cell lipidome during ZIKV infection using the MALDI Mass Spectrometry Imaging (MALDI-MSI) approach in order to identify and characterize important molecules associated with Aedes-ZIKV interactions. Our findings indicate that, as with DENV infection , Aedes’ cells increase their glycerophospholipid metabolism for some lipids, which may represent potential targets for blocking viral replication in mosquitoes or for further developments in novel therapeutic approaches in humans, since it is known that some factors required for viral infection are conserved among Diptera and human hosts .
The Aedes albopictus C6/36 cell line (ATCC® CRL-1660) was cultured in special Leibovitz L-15 medium (Vitrocell®), with 1% of essential amino acids, pyruvate, penicillin, streptomycin, and amphotericin (SigmalAldrich) and 10% of bovine fetal serum—BFS (Vitrocell®). These cells were conditioned at 28°C with 5% of CO2 at the Animal Virology Laboratory of the University of Campinas.
Zika virus isolate
Brazilian ZIVK strain (BeH823339, GenBank KU729217) was kindly provided by Professor Edison Durigon (Biomedical Sciences Institute, University of São Paulo). This viral strain was originally isolated by a team of the Evandro Chagas Institute, Pará State, Brazil from a Ceará’s State (Brazil) patient in 2015. The virus was stored at -80°C in the Animal Virology Laboratory of the University of Campinas until use. Before procedure, the viral titer in this stock was determined by PFU assay in Vero cells.
Infection of A. albopictus C6/36 cells with zika virus
For ZIKV infection, 1x105 cells of C6/36 cell line was added to each well of a 24-well plate, and incubated for 24 hours at 28°C with 5% of CO2. Viral Infection was performed using a multiplicity of infection (MOI) of 10. The plate was then incubated under 5% of CO2 at room temperature for five days. The choice of this timepoint was given because this was when cytopathic effects began to arise in the cell culture [23, 24]. The same procedure was carried out for the negative control samples, without ZIKV inoculation, resulting in 15 biological replicates for each condition studied.
Viral detection by RT-qPCR
In order to confirm ZIKV infection, the viral stock and the supernatant of ZIKV-infected C6/36 cells were assayed by real time RT-qPCR . Briefly, the viral RNA was isolated by a commercial kit following the manufacturer’s instruction (RNeasy Mini Kit, Qiagen, Hilden, Germany). One step RT-PCR amplification of viral RNA (Taqman RNA to-CT, Applied Biosystems) was performed with following primers and probes: ZIKV-F: 5’- CCGCTGCCCAACACAAG-3’; ZIKV-R: 5’- CCACTAACGTTCTTTTGCAGACAT -3’; ZIKV-P: 5’-/FAM/AGCCTACCTTGACAAGCAGTCAGACACTCAA/-3’. All reactions were assembled in a final volume of 12.5 μL with 300 ng of RNA, 1 PrimeTime mix (Integrated DNA Technologies) containing both primers and probe, and 6.25 μL of TaqMan master mix (Applied Biosystems) by using the following cycling algorithm: 48°C for 30 min, 95°C for 10 min, followed by 45 cycles of 95°C for 15 s and 60°C for 1 min.
Six days after infection, cells were placed on glass slides 24x60mm and covered with MALDI matrix α-cyano-4-hydroxycinnamic acid (Sigma-Aldrich, St. Louis, MO) solution at 10 mg/mL in 1:1 acetonitrile/methanol. Spectra were acquired using a MALDI LTQ-XL (Thermo Scientific, San Jose, CA) at the mass range of 400 to 1200 m/z, in the negative ion mode for a total of 15 replicates per group. MS/MS data were acquired in the same instrument, using Helium as the collision gas, with energies for collision-induced dissociation (CID) ranging from 20–80 (arbitrary units). Spectra were analyzed using XCalibur software (v. 2.4, Thermo Scientific, San Jose, CA).
Lipids were identified based on the analysis of the MS/MS fragmentation profile of the ions selected by statistical analyses. Structures were proposed using theoretical calculations modeling for molecular fragmentation using Mass Frontier software (v. 6.0, Thermo Scientific, San Jose, CA).
Semi quantification by MSI
Chemical images of the markers were generated using the imaging feature of MALDI and processed to grayscale using the ImageQuest software (Thermo Scientific, San Jose, CA). All samples, control and ZIKV, and each respective replicate (n = 15) had their chemical image standardized and analyzed using ImageJ software (National Institutes of Health, USA—open source). A non-dimensional value was assigned to each image based on pixel intensity, so that the intensity/quantity ratio is established .
Partial least squares discriminant analysis (PLS-DA) was used as the method of choice to assess association between groups; this supervised method uses multivariate regression techniques to extract, through linear combination of the original variables, the characteristics that may evidence this association. Statistical significance of the obtained model was assessed by using two permutation tests: precision preview during modeling and separation distance; 2000 permutations were used in both tests. The selection of lipids that were characteristic for each sample was carried out considering the impact that each metabolite had in the analysis through VIP (Variable Importance in Projection) scores, which consists of the weighted average of the squares of the PLS loadings, and takes into account the amount of explained variance on each dimension used in the model. As a cutoff threshold, only the chemical markers with a VIP score greater than 1.5 were analyzed. The heat map of the VIPs was built using the Pearson’s distance measurement and Ward’s clustering algorithm. All analyses involving PLS-DA and VIP scores were carried out using the online software MetaboAnalyst 3.0 .
For comparative purposes of semi-quantitative data, either Student’s t-test or Mann-Whitney’s U-test was used after applying Kolmogorov-Smirnov normal distribution test; a p-value was significant if it presented values lower than 0.05. All those calculations were carried out using the software GraphPad Prism (v.3.0, GraphPad Software, San Diego, CA).
In order to analyze the main metabolites involved with ZIKV infection in the mosquito, we performed a metabolomic analysis on Aedes albopictus C6/36 cells, either infected by the Brazilian ZIKV strain, or uninfected. Our data suggest that a large amount of lipids is involved in the responses to ZIKV infection. A PLS-DA statistical analysis of our mass spectrometry-derived data evidenced a clear separation between the metabolite composition in ZIKV-infected versus uninfected C6/36 mosquito control cells, as demonstrated in Fig 1; statistical validation of this PLS-DA model by permutation tests are provided on S1 Fig (prediction accuracy) and S2 Fig (prediction accuracy during training). Using VIP scores, 65 features were identified with a score value greater or equal to 1.5, as demonstrated in Fig 2; the ZIKV-infected cells accounted for 37 characteristic markers whereas the uninfected control ones displayed 28 molecules. Out of these 65 features, 20 lipid markers were identify using tandem mass spectrometry (MS/MS), divided in 13 species for the ZIKV-infected group (Table 1) and 7 for the control group (Table 2).
The explained variances are 33.5% for component 1 and 52.5% for component two.
Of the 13 lipids species indentified for ZIKV-infected cells (Table 1), 12 participate directly in the intracellular metabolism of glycerophospholipid in the host cells: 8 are acylglycerophospholipids, divided into 6 acylglycerophosphoserines and 2 acylglycerophosphocholines; 3 species are diacylglycerophospholipids, divided in two diacylglycerophosphocholines and 1 diacylglycerophosphoserine; 1 is a diacylglycerol; and one is a sphingolipid. Hence, our data suggest that the glycerophospholipid metabolism pathway activity is much increased in the ZIKV-infection group, similarly to other viral infections [14, 15, 28].
To corroborate the abovementioned evidence of ZIKV infection interference in the mosquito cells’ metabolism, a semi-quantitative analysis of characteristic lipids confirmed that ZIKV-infected cells presented statistically significant higher levels (p<0.05) of all PLS-DA-elected lipids previously elected as characteristic markers for ZIKV-infection based on the quantitative comparison performed with each marker between ZIKV-infection and control samples (Fig 3). We observed up to 2.15-fold higher concentration of metabolites such as ion at m/z 556 [PC(6:2(3E,5E)/14:2(11E,13E))] in ZIKV-infected cells when compared to non infected controls.
The bars representing confidence interval of 95% (**** p<0.0001)
Nevertheless, the quantitative comparison between the elected markers for control and ZIKV-infected cells was not statistically significant, despite a slight increase in the amount of elected markers in the control cells was observed (p<0.05, S3 Fig), suggesting that the same glycerophospholipid metabolic pathway is active in both the control and the ZIKV-infected cells. This may be explained by the fact that both ZIKV-infected and uninfected cells have essentially the same metabolic profile, except for some specific metabolic changes induced by the virus in the cell line [14, 29]; the regular glycerophospholipid metabolism, however, remain at lower levels when the cell is in homeostasis . Fig 4 presents a comparison between ZIKV-infected and non-infected cells, where it is visually possible to assess the differences in lipid composition of ZIKV-specific characterized biomarkers. The present study uses mosquito cells; however, the host factors identified may be the same as for the human host, since this has been shown in other studies on viral infections .
Sphingofungin F, the ion at m/z 400 (Table 1), was the SL found as marker for ZIKV infection. This compound was isolated for the first time during the fermentation of Paecilomyces variotii (ATCC 74097), and it is a bioactive lipid that acts as the inhibitor of serine palmitoyltransferase (SPT), an essential enzyme during the biosynthesis of SL (26). The SPT inhibitor was initially investigated for its antifungal activity; however, later studies showed that these inhibitors suppress viral replication, as described with for myriocin-based SPT inhibition in hepatitis C virus (HCV) [29, 31], as well as for 4-hydroxyphenyl retinamide inhibitor in a study with DENV . Like ZIKV, these two viruses also belong to the Flaviviridae family. No previous report has ever implicated this SL as an insect metabolite; it has only been associated to fungi metabolism . As observed in Fig 4, this molecule is present in both cultures, but the relative amount in the ZIKV-infected group is 1.64-fold (p<0.0001) higher than in the control group. This may be an indicative that the infected cells are responding to viral infection, in an attempt to impair viral replication.
PS is the most abundant anionic lipid class in the plasma membrane of eukaryotes. It is essentially produced in the inner side of the plasma membrane when the cell is in homeostasis; however, this asymmetry is lost during injury, malignancy, or the apoptosis [33, 34]. Under apoptotic conditions, cells reverse PS to the outer side of the membrane. PS signalize to phagocytes that cell is under apoptosis . The exact processes, by which the cell externalizes these lipids, or how this process is initiated, are not fully understood . Cell cultures were analyzed 7 days after seeding, which marks the beginning of the culture decay process. Hence, the two PS lipids elected as markers for the control group, m/z 881 [PS(22:4(7Z,10Z,13Z,16Z)/21:0)] and m/z 903 [PS(22:0/22:0)] may be due to the apoptotic process that may have been initiated in the cell culture, which lead to a higher dead cells ratio, as cell cultures are self-limiting in growth. Additionally, since both cultures were analyzed at the same time point, the ZIKV-infected group was likely in the same phase of the control one, which may explain the lack of statistical significance in the quantitative analysis of markers between these two groups.
The level of all 6 PS characterized for the ZIKV-infected culture, m/z 516 [PS(18:4(6Z,9Z,12Z,15Z)/0:0)], m/z 518 [PS(18:3(9Z,12Z,15Z)/0:0)], m/z 520 [PS(18:2(9Z,12Z)/0:0)], m/z 540 [PS(20:6(2Z,5Z,8Z,11Z,14Z,17Z)/0:0)], m/z 542 [PS(20:5(5Z,8Z,11Z,14Z,17Z)/0:0)] and m/z 544 [PS(20:4(5Z,8Z,11Z,14Z)/0:0)], was statistically significant in the semi-quantitative analysis when compared to the control uninfected culture, as shown in Fig 3. PS seems to play a crucial role during virus infection [8, 11, 34]. The viral infection, in turn, induces asymmetry in plasma membrane composition, similar to the abovementioned apoptotic process, facilitating phagocyte recognition of infected cells [37–40]. In addition, viral envelope phosphatidylserine are essential for viral replication, mediating biding to target cells or phagocytosis of viral particles, such as demonstrated for West Nile, Dengue and Ebola viruses [8, 11]. Several recognition mechanisms of apoptotic cells by phagocytes were described during the infection of several viruses, such as those that recognize CD300a, TIM and TAM receptors, observed in DENV infection [8, 9]. In addition, the availability of PS in the outer side of circulating infected-cells signals through TAM receptors to tighten cell junctions, modulating blood-brain barrier integrity and preventing virus transit across brain microvascular endothelial cells during viral infection .
PE, as well as PS, is an anionic lipid that is normally found in the inner side of plasma membranes [33, 34], and are synthesized via the decarboxylation reaction of PS [42, 43]. It is the second most abundant lipid class in plasma membranes, after phosphatidylcholines (PC) . PE is externalized upon any cellular biochemical imbalance [33, 34], probably by the same mechanism of PS, indicating that apoptosis is underway . As for PS, the three PE elected as markers for the control group (m/z 757 [PE(18:2(9Z,12Z)/19:0)], m/z 773 [PE(20:0/18:1(9Z))] and m/z 779 [PE(16:0/22:6(54Z,7Z,10Z,12E,16Z,19Z)(14OH))]) did not present significant differences in content when compared to the ZIKV-infected group (data not shown). Since PS and PE play the same role during apoptosis signaling , the same premises presented above may explain the lack of significance in this comparison.
PE, as well as PS, is a substrate for TAM  and CD300a  receptors, involved in viral internalization into the cell. The species elected as marker for the ZIKV-infected group, m/z 632 [PE(12:0/16:1(9Z))], presented statistically significant differences in the semi-quantitative analysis (Fig 3), probably due to a cellular response mechanism that uses this particular PE as an alert signal for phagocytes upon viral infection . Another potential explanation is that this PE is a component of the viral envelope during its replication (Fig 4).
PC is the most abundant plasma membrane phospholipid, and its distribution, as opposed to PE and PS, is on the outer side of the membrane . PC was only elected as marker for the ZIKV-infected group, which presented greater amount of this compound when compared to the -uninfected one (Table 1). This is in agreement with similar findings reported for DENV-infected cell cultures [14, 15]. The 4 PC elected as markers for ZIKV infection (m/z 530 [PC(19:3(10Z,13Z,16Z)/0:0)], m/z 536 [PC(19:0/0:0)], m/z 556 [PC(6:2(3E,5E)/14:2(11E,13E))] and m/z 558 [PC(6:2(3E,5E)/14:1(13E))]) also presented statistically significant quantitative differences (Fig 3), evidencing that there is a greater amount of these lipids in the ZIKV-infected group, compared to the control one. Two out of the PC elected as markers of ZIKV have already been previously associated to cell response against infectious agents. The ion at m/z 530, which corresponds to PC(19:3(10Z,13Z,16Z)/0:0) has already been found on the metabolome of bile acids in patients with altered microbiota and pyloric sphincter . Ion m/z 536, corresponding to PC(19:0/0:0) was reported in a lipidomics study that analyzed inflammatory mediators as potential biomarkers for bacteremia ; however, in this study made with blood plasma, this species was implicated as a marker of uninfected, bacteremia-free patients, as opposed to what was found in our in vitro study. Such difference may be due to either the pathogen used in the study or the study type (in vivo vs. in vitro); in either case, both lipids are associated with a cell response to an infectious agent, whose mechanism is yet to be elucidated [46, 47].
Furthermore, another study has demonstrated that infections caused by positive RNA viruses, such as ZIKV, promote an increase or accumulation of PC—which is utilized in the formation of viral replication complex (VRC), and also for the replication of the virus in the VRC –a potential explanation for why those are the markers displaying the greatest amounts in ZIKV-infected cells when compared to the -uninfected ones (1.74-fold for ion 530 m/z, 1.96-fold for ion 536 m/z, 2.15-fold for ion 556 m/z and 1.94-fold for ion 558 m/z).
Other lipid classes
Three other lipids were identified as markers: two for the control group, a phosphatidic acid at m/z 409, PA(16:0/0:0), and a triacylglycerol at m/z 925, TG(18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)); and one for the ZIKV group, a diacylglycerol at m/z 925, DG(16:1(9Z)/16:1(9Z)/0:0). The latter may be explained due to the increased metabolic activity of ZIKV-infected cells, since DG is part of PE and PC synthesis, as well as Kennedy Pathways [28, 48]. Once again, the other two elected markers for the control group did not present significant differences in the semiquantification when compared to the ZIKV group, indicating that these species may be common in both cell cultures.
Our findings suggest that PS, PE, SL and PC specific-lipids are putative biomarkers of ZIKV infection in C6/36 mosquito cells. These results are in line with previous lipidomics studies of virus-infected cells. Previous contributions, especially those that studied the same cell line (C36/6 mosquito cells) infected with DENV, have observed increased profiles of lipids such as phosphaditylcholines (PC), phosphatidylethanolamines (PE) and phosphatidylserines (PS) compared to the control cells , which are exactly the same view in our study. Furthermore, other recent study also demonstrated higher level of lipid classes of PC, PE, PS and phosphatidylglycerols (PG) during infection of brome mosaic virus (BMV) in YPH500 yeast , indicating that these lipids are intimately involved with viral infection/replication in different cell types and organisms. Hence, our results provide valuable information on metabolites that may be used as therapeutic targets for further studies.
S1 Fig. PLS-DA model validation by permutation tests based on prediction accuracy.
The p value based on permutation is p<5e-04 (0/2000).
S2 Fig. PLS-DA model validation by permutation tests based on prediction accuracy during training.
The p value based on permutation is p < 5e-04 (0/2000).
We are thankful to Professor Edson Durigon for kindly providing the ZIKV viral stocks used in this work. We acknowledge funding from Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP—São Paulo Research Foundation), under the following Grant numbers: 2011/50400-0 and 2015/06809-1 for RRC, 2014/00084-2 for DNO, 2014/00302-0 for CZE, 2013/11343-6 Young Investigator for JASN). We also thank CAPES and CNPq for the fellowships for CFORM, EOL and TMG.
- Conceptualization: RRC JASN JLPM CWA.
- Formal analysis: CFORM.
- Funding acquisition: RRC JASN JLPM.
- Investigation: CFORM RMB MAP.
- Methodology: RRC JASN JLPM CWA.
- Project administration: RRC.
- Resources: RRC JASN JLPM CWA.
- Supervision: RRC.
- Validation: GPM.
- Visualization: CFORM DNO EOL TMG CZE.
- Writing – original draft: CFORM DNO EOL TMG CZE.
- Writing – review & editing: CFORM DNO EOL TMG CZE.
- 1. Brunner M, Koskinen AM. Biology and Chemistry of Sphingosine-Related Metabolites. Current Organic Chemistry. 2004;8(17):1629–45.
- 2. Chang C, Ortiz K, Ansari A, Gershwin ME. The Zika outbreak of the 21st century. Journal of autoimmunity. 2016;68:1–13. pmid:26925496
- 3. Cao-Lormeau V-M, Blake A, Mons S, Lastère S, Roche C, Vanhomwegen J, et al. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. The Lancet. 2016;387(10027):1531–9. pmid:26948433
- 4. Brasil P, Pereira J, Jose P, Raja Gabaglia C, Damasceno L, Wakimoto M, Ribeiro Nogueira RM, et al. Zika virus infection in pregnant women in Rio de Janeiro—preliminary report. New England Journal of Medicine. 2016. pmid:26943629
- 5. Faria NR, da Silva Azevedo RdS, Kraemer MU, Souza R, Cunha MS, Hill SC, et al. Zika virus in the Americas: Early epidemiological and genetic findings. Science. 2016;352(6283):345–9. pmid:27013429
- 6. Lindenbach BD, Rice CM. Molecular biology of flaviviruses. Advances in virus research. 2003;59:23–62. pmid:14696326
- 7. Stiasny K, Koessl C, Heinz FX. Involvement of lipids in different steps of the flavivirus fusion mechanism. Journal of virology. 2003;77(14):7856–62. pmid:12829825
- 8. Carnec X, Meertens L, Dejarnac O, Perera-Lecoin M, Hafirassou ML, Kitaura J, et al. The phosphatidylserine and phosphatidylethanolamine receptor CD300a binds dengue virus and enhances infection. Journal of virology. 2016;90(1):92–102. pmid:26468529
- 9. Meertens L, Carnec X, Lecoin MP, Ramdasi R, Guivel-Benhassine F, Lew E, et al. The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell host & microbe. 2012;12(4):544–57. pmid:23084921
- 10. Moller-Tank S, Kondratowicz AS, Davey RA, Rennert PD, Maury W. Role of the phosphatidylserine receptor TIM-1 in enveloped-virus entry. Journal of virology. 2013;87(15):8327–41. pmid:23698310
- 11. Morizono K, Chen IS. Role of phosphatidylserine receptors in enveloped virus infection. Journal of virology. 2014;88(8):4275–90. pmid:24478428
- 12. Morizono K, Xie Y, Olafsen T, Lee B, Dasgupta A, Wu AM, et al. The soluble serum protein Gas6 bridges virion envelope phosphatidylserine to the TAM receptor tyrosine kinase Axl to mediate viral entry. Cell host & microbe. 2011;9(4):286–98. pmid:21501828
- 13. Richard AS, Zhang A, Park S-J, Farzan M, Zong M, Choe H. Virion-associated phosphatidylethanolamine promotes TIM1-mediated infection by Ebola, dengue, and West Nile viruses. Proceedings of the National Academy of Sciences. 2015;112(47):14682–7. pmid:26575624
- 14. Zhang J, Zhang Z, Chukkapalli V, Nchoutmboube JA, Li J, Randall G, et al. Positive-strand RNA viruses stimulate host phosphatidylcholine synthesis at viral replication sites. Proceedings of the National Academy of Sciences. 2016;113(8):E1064–E73. pmid:26858414
- 15. Perera R, Riley C, Isaac G, Hopf-Jannasch AS, Moore RJ, Weitz KW, et al. Dengue virus infection perturbs lipid homeostasis in infected mosquito cells. PLoS Pathog. 2012;8(3):e1002584. pmid:22457619
- 16. Barletta ABF, Alves LR, Silva MCLN, Sim S, Dimopoulos G, Liechocki S, et al. Emerging role of lipid droplets in Aedes aegypti immune response against bacteria and Dengue virus. Scientific reports. 2016;6. pmid:26887863
- 17. Sánchez-Vargas I, Scott JC, Poole-Smith BK, Franz AW, Barbosa-Solomieu V, Wilusz J, et al. Dengue virus type 2 infections of Aedes aegypti are modulated by the mosquito's RNA interference pathway. PLoS Pathog. 2009;5(2):e1000299. pmid:19214215
- 18. Souza-Neto JA, Sim S, Dimopoulos G. An evolutionary conserved function of the JAK-STAT pathway in anti-dengue defense. Proceedings of the National Academy of Sciences. 2009;106(42):17841–6. pmid:19805194
- 19. Xi Z, Ramirez JL, Dimopoulos G. The Aedes aegypti toll pathway controls dengue virus infection. PLoS Pathog. 2008;4(7):e1000098. pmid:18604274
- 20. Fauci AS, Morens DM. Zika Virus in the Americas—Yet Another Arbovirus Threat. New England Journal of Medicine. 2016. pmid:26761185
- 21. Ginier M, Neumayr A, Günther S, Schmidt-Chanasit J, Blum J. Zika without symptoms in returning travellers: What are the implications? Travel medicine and infectious disease. 2016;14(1):16–20. pmid:26876061
- 22. Sessions OM, Barrows NJ, Souza-Neto JA, Robinson TJ, Hershey CL, Rodgers MA, et al. Discovery of insect and human dengue virus host factors. Nature. 2009;458(7241):1047–50. pmid:19396146
- 23. Gliedman JB, Smith JF, Brown D. Morphogenesis of Sindbis virus in cultured Aedes albopictus cells. Journal of virology. 1975;16(4):913–26. pmid:170422
- 24. Hematian A, Sadeghifard N, Mohebi R, Taherikalani M, Nasrolahi A, Amraei M, et al. Traditional and Modern Cell Culture in Virus Diagnosis. Osong public health and research perspectives. 2016;7(2):77–82. pmid:27169004
- 25. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 2008;14(8):1232–9. pmid:18680646
- 26. De Oliveira DN, de Bona Sartor S, Ferreira MS, Catharino RR. Cosmetic analysis using matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI). Materials. 2013;6(3):1000–10.
- 27. Xia J, Sinelnikov IV, Han B, Wishart DS. MetaboAnalyst 3.0—making metabolomics more meaningful. Nucleic acids research. 2015;43(W1):W251–W7. pmid:25897128
- 28. Gibellini F, Smith TK. The Kennedy pathway—de novo synthesis of phosphatidylethanolamine and phosphatidylcholine. IUBMB life. 2010;62(6):414–28. pmid:20503434
- 29. Amemiya F, Maekawa S, Itakura Y, Kanayama A, Matsui A, Takano S, et al. Targeting lipid metabolism in the treatment of hepatitis C virus infection. Journal of Infectious Diseases. 2008;197(3):361–70. pmid:18248300
- 30. Soulages JL, Wu Z, Firdaus SJ, Mahalingam R, Arrese EL. Monoacylglycerol and diacylglycerol acyltransferases and the synthesis of neutral glycerides in Manduca sexta. Insect biochemistry and molecular biology. 2015;62:194–210. pmid:25263765
- 31. Umehara T, Sudoh M, Yasui F, Matsuda C, Hayashi Y, Chayama K, et al. Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model. Biochemical and biophysical research communications. 2006;346(1):67–73. pmid:16750511
- 32. Carocci M, Hinshaw SM, Rodgers MA, Villareal VA, Burri DJ, Pilankatta R, et al. The bioactive lipid 4-hydroxyphenyl retinamide inhibits flavivirus replication. Antimicrobial agents and chemotherapy. 2015;59(1):85–95. pmid:25313218
- 33. Balasubramanian K, Schroit AJ. Aminophospholipid asymmetry: a matter of life and death. Annual review of physiology. 2003;65(1):701–34. pmid:12471163
- 34. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 1997;89(4):1121–32. pmid:9028933
- 35. Fadok VA, Bratton DL, Frasch SC, Warner ML, Henson PM. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell death and differentiation. 1998;5(7):551–62. pmid:10200509
- 36. Lee S-H, Meng XW, Flatten KS, Loegering DA, Kaufmann SH. Phosphatidylserine exposure during apoptosis reflects bidirectional trafficking between plasma membrane and cytoplasm. Cell Death & Differentiation. 2013;20(1):64–76. pmid:22858544
- 37. Barathan M, Gopal K, Mohamed R, Ellegård R, Saeidi A, Vadivelu J, et al. Chronic hepatitis C virus infection triggers spontaneous differential expression of biosignatures associated with T cell exhaustion and apoptosis signaling in peripheral blood mononucleocytes. Apoptosis. 2015;20(4):466–80. pmid:25577277
- 38. Mercer J, Helenius A. Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science. 2008;320(5875):531–5. pmid:18436786
- 39. Soares MM, King SW, Thorpe PE. Targeting inside-out phosphatidylserine as a therapeutic strategy for viral diseases. Nature medicine. 2008;14(12):1357–62. pmid:19029986
- 40. Takizawa T, Matsukawa S, Higuchi Y, Nakamura S, Nakanishi Y, Fukuda R. Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. Journal of General Virology. 1993;74(11):2347–55. pmid:7504071
- 41. Miner JJ, Daniels BP, Shrestha B, Proenca-Modena JL, Lew ED, Lazear HM, et al. The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity. Nature medicine. 2015;21(12):1464–72. pmid:26523970
- 42. Trotter PJ, Voelker DR. Identification of a non-mitochondrial phosphatidylserine decarboxylase activity (PSD2) in the yeast Saccharomyces cerevisiae. Journal of Biological Chemistry. 1995;270(11):6062–70. pmid:7890739
- 43. Zinser E, Sperka-Gottlieb C, Fasch E-V, Kohlwein SD, Paltauf F, Daum G. Phospholipid synthesis and lipid composition of subcellular membranes in the unicellular eukaryote Saccharomyces cerevisiae. Journal of bacteriology. 1991;173(6):2026–34. pmid:2002005
- 44. Maulik N, Kagan VE, Tyurin VA, Das DK. Redistribution of phosphatidylethanolamine and phosphatidylserine precedes reperfusion-induced apoptosis. American Journal of Physiology-Heart and Circulatory Physiology. 1998;274(1):H242–H8. pmid:9458873
- 45. Verkleij A, Leunissen-Bijvelt J, De Kruijff B, Mt Hope, Cullis P, editors. Non-Bilayer Structures in Membrane Fusion. Ciba Foundation Symposium 103-Cell Fusion; 1984: Wiley Online Library.
- 46. Liang T, Su W, Zhang Q, Li G, Gao S, Lou J, et al. Roles of Sphincter of Oddi Laxity in Bile Duct Microenvironment in Patients with Cholangiolithiasis: From the Perspective of the Microbiome and Metabolome. Journal of the American College of Surgeons. 2015. pmid:26922601
- 47. To KK, Lee K-C, Wong SS, Lo K-C, Lui Y-M, Jahan AS, et al. Lipid mediators of inflammation as novel plasma biomarkers to identify patients with bacteremia. Journal of Infection. 2015;70(5):433–44. pmid:25727996
- 48. Boumann HA, de Kruijff B, Heck AJ, de Kroon AI. The selective utilization of substrates in vivo by the phosphatidylethanolamine and phosphatidylcholine biosynthetic enzymes Ept1p and Cpt1p in yeast. FEBS letters. 2004;569(1):173–7. pmid:15225629